Jonas Walter
Jonas Walter
NNF Center for Protein Research
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression
N Govindarajan, RC Agis-Balboa, J Walter, F Sananbenesi, A Fischer
Journal of Alzheimer's Disease 26 (1), 187-197, 2011
Distinct antimicrobial peptide expression determines host species-specific bacterial associations
S Franzenburg, J Walter, S Künzel, J Wang, JF Baines, TCG Bosch, ...
Proceedings of the National Academy of Sciences 110 (39), E3730-E3738, 2013
Derivation of human midbrain-specific organoids from neuroepithelial stem cells
AS Monzel, LM Smits, K Hemmer, S Hachi, EL Moreno, T van Wuellen, ...
Stem cell reports 8 (5), 1144-1154, 2017
3D cultures of Parkinson's disease‐specific dopaminergic neurons for high content phenotyping and drug testing
S Bolognin, M Fossépré, X Qing, J Jarazo, J Ščančar, EL Moreno, ...
Advanced Science 6 (1), 1800927, 2019
FACS-assisted CRISPR-Cas9 genome editing facilitates Parkinson's disease modeling
J Arias-Fuenzalida, J Jarazo, X Qing, J Walter, G Gomez-Giro, SL Nickels, ...
Stem Cell Reports 9 (5), 1423-1431, 2017
CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons
X Qing, J Walter, J Jarazo, J Arias-Fuenzalida, AL Hillje, JC Schwamborn
Stem Cell Research 24, 44-50, 2017
Neural stem cells of Parkinson's disease patients exhibit aberrant mitochondrial morphology and functionality
J Walter, S Bolognin, PMA Antony, SL Nickels, SK Poovathingal, ...
Stem cell reports 12 (5), 878-889, 2019
Impaired mitochondrial–endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson’s disease
C Berenguer-Escuder, D Grossmann, P Antony, G Arena, K Wasner, ...
Human molecular genetics 29 (8), 1353-1364, 2020
Impaired serine metabolism complements LRRK2-G2019S pathogenicity in PD patients
SL Nickels, J Walter, S Bolognin, D Gérard, C Jaeger, X Qing, J Tisserand, ...
Parkinsonism & related disorders 67, 48-55, 2019
Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release
T Narita, S Ito, Y Higashijima, WK Chu, K Neumann, J Walter, S Satpathy, ...
Molecular Cell 81 (10), 2166-2182. e6, 2021
Automated high-throughput high-content autophagy and mitophagy analysis platform
J Arias-Fuenzalida, J Jarazo, J Walter, G Gomez-Giro, JI Forster, ...
Scientific reports 9 (1), 1-11, 2019
Parkinson’s disease phenotypes in patient specific brain organoids are improved by HP-β-CD treatment
J Jarazo, K Barmpa, I Rosety, LM Smits, J Arias-Fuenzalida, J Walter, ...
Biorxiv, 813089, 2019
The Parkinson’s-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1
J Walter, S Bolognin, SK Poovathingal, S Magni, D Gérard, PMA Antony, ...
Cell Reports 37 (3), 109864, 2021
Human induced pluripotent stem cell-derived neuronal progenitors are a suitable and effective drug discovery model for neurological mtDNA disorders
J Walter, SL Nickels, JC Schwamborn
Stem cell investigation 4, 2017
Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2‐Hydroxypropyl‐β‐Cyclodextrin Treatment
J Jarazo, K Barmpa, J Modamio, C Saraiva, S Sabaté‐Soler, I Rosety, ...
Movement Disorders, 2021
2-hydroxypropyl-beta-cyclodextrin for use in a method of treatment of a parkinsonian condition
J Jarazo, J Walter, J Schwamborn
LU Patent WO2019219741A1, 2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–16